Milbemax

Milbemax is a broad-spectrum allwormer tablet for dogs and cats, manufactured by Elanco Animal Health — the world's third-largest animal health company. Originally developed under Novartis Animal Health, Milbemax became part of the Elanco portfolio following their $5.4 billion acquisition of Novartis in 2014.

Milbemax treats and controls all major intestinal worms including roundworm, hookworm, whipworm, and tapeworm. When administered monthly, it also prevents heartworm disease. The tablets are available in size-specific doses for puppies, small dogs, and large dogs, and are safe for use in breeding, pregnant, and lactating dogs. Widely available through vets and pet retailers across Australia.